Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
42
COSM Quote, Financials, Valuation and Earnings
Last price:
$0.55
Seasonality move
:
-8.53%
Day range:
$0.51 - $0.57
52-week range:
$0.28 - $1.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.25x
P/B ratio:
0.83x
Volume:
1.1M
Avg. volume:
612.7K
1-year change:
-13.58%
Market cap:
$19.2M
Revenue:
$54.4M
EPS (TTM):
-$0.71
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Cosmos Health, Inc. has 445.55% upside to fair value with a price target of $3.00 per share.
COSM vs. S&P 500
-
Over the past 5 trading days, Cosmos Health, Inc. has overperformed the S&P 500 by 5.12% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cosmos Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cosmos Health, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Cosmos Health, Inc. reported revenues of $17.1M.
Earnings Growth
-
Cosmos Health, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Cosmos Health, Inc. reported earnings per share of -$0.17.
Enterprise value:
38.7M
EV / Invested capital:
--
Price / LTM sales:
0.25x
EV / EBIT:
--
EV / Revenue:
0.65x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-3.71x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$5.5M
Return On Assets:
-30.16%
Net Income Margin (TTM):
-31.01%
Return On Equity:
-68.76%
Return On Invested Capital:
-44.07%
Operating Margin:
-10.63%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $49.6M | $54.3M | $59.8M | $12.4M | $17.1M | |
| Gross Profit | $3.1M | $3.4M | $5.5M | $902.7K | $2.2M | |
| Operating Income | -$15.7M | -$21.3M | -$13.4M | -$2.2M | -$1.8M | |
| EBITDA | -$15.3M | -$20.3M | -$12.1M | -$1.9M | -$1.4M | |
| Diluted EPS | -$4.22 | -$2.19 | -$0.71 | -$0.45 | -$0.17 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $44.3M | $38.8M | $46.5M | $36.2M | $38.1M | |
| Total Assets | $47.7M | $45.6M | $71.6M | $64.5M | $69.5M | |
| Current Liabilities | $37.4M | $36.9M | $22.6M | $25.2M | $38.5M | |
| Total Liabilities | $43M | $42.2M | $27M | $29.5M | $46.4M | |
| Total Equity | $4.7M | $3.4M | $44.6M | $35M | $23.1M | |
| Total Debt | $5.6M | $5.4M | $5.2M | $4.8M | $9.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$30.1M | -- | -$9.4M | -$281.4K | -$4M | |
| Cash From Investing | -$10.4M | -- | -$2M | -$35.4K | -$1M | |
| Cash From Financing | $42.2M | -- | $12.7M | $3.7M | $8.7M | |
| Free Cash Flow | -$34.1M | -- | -$10.5M | -$510.2K | -$4M | |
COSM
Sector
Market Cap
$19.2M
$28.1M
Price % of 52-Week High
41.66%
51.87%
Dividend Yield
0%
0%
Shareholder Yield
-9.89%
-1.59%
1-Year Price Total Return
-13.58%
-17.31%
Beta (5-Year)
4.381
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.52
200-day SMA
Sell
Level
$0.64
Bollinger Bands (100)
Sell
Level
0.56 - 1
Chaikin Money Flow
Buy
Level
15.7M
20-day SMA
Buy
Level
$0.50
Relative Strength Index (RSI14)
Buy
Level
52.12
ADX Line
Buy
Level
13.2
Williams %R
Neutral
Level
-20.1
50-day SMA
Sell
Level
$0.61
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
443.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.5522)
Sell
CA Score
(Annual)
Level (-1.2406)
Buy
Beneish M-Score
(Annual)
Level (-3.7286)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.8535)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.
Stock Forecast FAQ
In the current month, COSM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The COSM average analyst price target in the past 3 months is $3.00.
-
Where Will Cosmos Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cosmos Health, Inc. share price will rise to $3.00 per share over the next 12 months.
-
What Do Analysts Say About Cosmos Health, Inc.?
Analysts are divided on their view about Cosmos Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cosmos Health, Inc. is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Cosmos Health, Inc.'s Price Target?
The price target for Cosmos Health, Inc. over the next 1-year time period is forecast to be $3.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is COSM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cosmos Health, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of COSM?
You can purchase shares of Cosmos Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cosmos Health, Inc. shares.
-
What Is The Cosmos Health, Inc. Share Price Today?
Cosmos Health, Inc. was last trading at $0.55 per share. This represents the most recent stock quote for Cosmos Health, Inc.. Yesterday, Cosmos Health, Inc. closed at $0.55 per share.
-
How To Buy Cosmos Health, Inc. Stock Online?
In order to purchase Cosmos Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get COSM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
COSM
Sector
P/E ratio
--
24.20x
PEG ratio
--
-0.01x
P/B ratio
0.83x
1.84x
Price / LTM sales
0.25x
1.60x
Growth Metrics
COSM
Sector
Revenue growth
37.87%
4.51%
Earnings growth
61.57%
10.7%
Revenue (5-year growth)
6.53%
6.45%
Earnings forecast
-$0.09
-$0.19
Profitability
COSM
Sector
Profitability FY 2024
$3.1M
$3.5M
Return on invested capital
-44.07%
-32.3%
Return on assets
-30.16%
-28.57%
Return on equity
-68.76%
-38.09%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
Jan
10
Estimated Next Earnings Date
Apr
11
Balance Sheet
COSM
Sector
Total cash
$4.7M
$26M
Short term investments
$21.2K
$25.7M
Total assets
$54.3M
$76.4M
Long term debt
$9.7M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
